HLXA insider transactions
Helix Acquisition Corp. (HLXA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for HLXA
- SEC Form 4 filed by Sturge Simon4 - MoonLake Immunotherapeutics (0001821586) (Issuer)
- SEC Form 4 filed by Xavier Ramnik4 - MoonLake Immunotherapeutics (0001821586) (Issuer)
- SEC Form 4 filed by Moukheibir Catherine4 - MoonLake Immunotherapeutics (0001821586) (Issuer)
- SEC Form 4 filed by Phillips Andrew John4 - MoonLake Immunotherapeutics (0001821586) (Issuer)
- SEC Form 3: New insider Bvf Partners L P/Il claimed ownership of 21,691,694 units of Class A Ordinary Shares3 - MoonLake Immunotherapeutics (0001821586) (Issuer)
- SEC Form 3: New insider Reich Kristian claimed ownership of 3,363,870 units of Class C ordinary shares3 - MoonLake Immunotherapeutics (0001821586) (Issuer)
- SEC Form 3 filed by new insider Phillips Andrew John3 - MoonLake Immunotherapeutics (0001821586) (Issuer)
- SEC Form 3: New insider Sturge Simon claimed ownership of 342,980 units of Class C ordinary shares3 - MoonLake Immunotherapeutics (0001821586) (Issuer)
- SEC Form 3: New insider Santos Da Silva Jorge claimed ownership of 3,363,870 units of Class C ordinary shares3 - MoonLake Immunotherapeutics (0001821586) (Issuer)
- SEC Form 3: New insider Bodenstedt Matthias claimed ownership of 915,376 units of Class C ordinary shares3 - MoonLake Immunotherapeutics (0001821586) (Issuer)
- SEC Form 3 filed by new insider Xavier Ramnik3 - MoonLake Immunotherapeutics (0001821586) (Issuer)
- SEC Form 3 filed by new insider Lassen Kara3 - MoonLake Immunotherapeutics (0001821586) (Issuer)
- SEC Form 3 filed by new insider Loy Spike3 - MoonLake Immunotherapeutics (0001821586) (Issuer)
- SEC Form 3 filed by new insider Moukheibir Catherine3 - MoonLake Immunotherapeutics (0001821586) (Issuer)
- SEC Form 4: Helix Holdings Llc converted options into 2,785,000 units of Class A Ordinary Shares4 - MoonLake Immunotherapeutics (0001821586) (Issuer)
- SEC Form 4: Chen Bihua converted options into 2,785,000 units of Class A Ordinary Shares and bought $28,500,000 worth of Class A Ordinary Shares (2,850,000 units at $10.00)4 - MoonLake Immunotherapeutics (0001821586) (Issuer)